Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Enterprise Value (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Enterprise Value for 3 consecutive years, with -$291.3 million as the latest value for Q1 2026.

  • Quarterly Enterprise Value fell 662.74% to -$291.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$291.3 million through Jan 2026, down 662.74% year-over-year, with the annual reading at -$237.6 million for FY2025, 2780.29% down from the prior year.
  • Enterprise Value for Q1 2026 was -$291.3 million at Kestra Medical Technologies, down from -$175.4 million in the prior quarter.
  • The five-year high for Enterprise Value was -$8.2 million in Q2 2024, with the low at -$291.3 million in Q1 2026.
  • Average Enterprise Value over 3 years is -$127.1 million, with a median of -$100.0 million recorded in 2024.
  • Peak annual rise in Enterprise Value hit 101.28% in 2025, while the deepest fall reached 2780.29% in 2025.
  • Over 3 years, Enterprise Value stood at -$76.9 million in 2024, then crashed by 128.07% to -$175.4 million in 2025, then tumbled by 66.07% to -$291.3 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$291.3 million, -$175.4 million, and -$201.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.